SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004032
Filing Date
2017-05-10
Accepted
2017-05-09 17:59:54
Documents
90
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20170331x10q.htm 10-Q 2172057
2 EX-31.1 amph-20170331ex31164719f.htm EX-31.1 23040
3 EX-31.2 amph-20170331ex312bab52f.htm EX-31.2 23166
4 EX-32.1 amph-20170331ex3217675f3.htm EX-32.1 12337
5 EX-32.2 amph-20170331ex32289b8ef.htm EX-32.2 12310
  Complete submission text file 0001558370-17-004032.txt   9952982

Data Files

Seq Description Document Type Size
6 EX-101.INS amph-20170331.xml EX-101.INS 2420058
7 EX-101.SCH amph-20170331.xsd EX-101.SCH 73800
8 EX-101.CAL amph-20170331_cal.xml EX-101.CAL 56666
9 EX-101.DEF amph-20170331_def.xml EX-101.DEF 266394
10 EX-101.LAB amph-20170331_lab.xml EX-101.LAB 514322
11 EX-101.PRE amph-20170331_pre.xml EX-101.PRE 463943
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 17827809
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences